The Patent Finder

Terms ending in 2028

GlaxoSmithKline LLC

Every in-force patent on GlaxoSmithKline LLC's record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US RE44,613N-Substituted Glycine Derivatives: Hydroxylase Inhibitors
In force
 · Low confidence
GlaxoSmithKline LLCIn forceLow confidence
US 8,022,032Method for Customized Dispensing of Variable Dose Drug Combination Products for Individualizing of Therapies
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 8,946,278INHIBITORS OF AkT ACTIVITY
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 8,637,563A Non-Peptide Thrombopoietin Receptor Agonist in the Treatment of Cancer and Pre-Cancerous Syndromes
In force
 · Medium confidence
Novartis AGIn forceMedium confidence
US 7,902,394Calcilytic Compounds
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 9,597,294Continuous Coating of Pellets
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 9,238,628Phenyl Amino Pyrimidine Compounds and Uses Thereof
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 12,570,614Phenyl Amino Pyrimidine Compounds and Uses Thereof
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US D701,957Nasal Dilator
In force
 · Medium confidence
GlaxoSmithKline LLCIn forceMedium confidence
US D703,318Nasal Dilator
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
11 more term ends in 2028 · Pro
10 of 21 patents shown. Soonest term end first, then patent number.
Pro members see all 21, including 11 expiring within the 18 months from Nov 19, 2026.
Upgrade to Pro
15 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited